// App-Quantinova.ai

2066 : Prognostication for Advanced Stage Hodgkin Lymphoma (HL) in the Modern Era: A Project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Researchers

Presenter

  • Angie Mae Rodday

Principal Investigators

  • Susan K Parsons

  • Carlton Scharman

  • Ranjana Advani

  • Massimo Federico

  • Jonathan W. Friedberg

  • Andrea Gallamini

  • David C. Hodgson

  • Peter Hoskin

  • Martin Hutchings

  • Peter Johnson

  • Kara M. Kelly

  • Brian K. Link

  • John A. Radford

  • Pier Luigi Zinzani

  • James R. Cerhan

  • John Raemaekers

  • Andrew M. Evens

Medical Centers

  • Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA

  • Tufts Medical Center, Tufts University School of Medicine, Boston, MA

  • Division of Oncology, Department of Medicine, Saul A. Rosenberg Professor of Lymphoma, Stanford Cancer Institute, Stanford, CA

  • CHIMOMO department, Università degli Studi di Modena e Reggio Emilia, Modena, Italy

  • Division of Endocrinology, University of Rochester, Rochester, NY

  • Research Innovation and Statistics, Antoine-Lacassagne Cancer Centre, Nice, France

  • Department of Medical Imaging, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

  • Mount Vernon Hospital, London, GBR

  • Department of Hematology; Finsen Centre, National Hospital, Copenhagen University Hospital, Copenhagen, Denmark

  • Southampton General Hospital School of Medicine, Southampton, United Kingdom

  • Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

  • Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA

  • The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom

  • Istituto di Ematologia "Seràgnoli", Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università degli Studi, Bologna, Italy

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

  • Radboud University Medical Center, Njmegen, Netherlands

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Locations

  • United States

  • Italy

  • France

  • Canada

  • Denmark

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

  • Solid malignancies

Biomarkers

  • Estrogen receptor alpha

  • Human albumin

  • White Blood Cell

Drug/Treatment

  • HD0801

Outcome

  • N/A


Study Design

  • Multinational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A